Gevokizumab
Cat. No.: IBDI-431849
Gevokizumab is a potent anti-IL-1β antibody, negatively modulates IL-1β signaling through an allosteric mechanism. Gevokizumab selectively decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor instead of IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).
Product Details
| Target |
Interleukin Related |
| Appearance |
Liquid |
| SMILES |
[Gevokizumab] |
| Purity |
98.12% |
Storage & Handling
| Shipping |
Shipping with dry ice. |
| Storage |
Please store the product under the recommended conditions in the Certificate of Analysis. |
| Regulatory Status |
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. |
! For research use only, not intended for any clinical use.
